Figure 1.
Flowchart for patients screening. A: Total dermatomyositis cohort was the final studied patients, which were divided into observation (malignant) and control (nonmalignant) groups. B: Malignant patients were the observation group, who acted as the basis for randomly selecting nonmalignant patients according to age and gender in a ratio of 1:2.